Nov. 6, 2024 – The FDA has updated the labels for all GLP-1 weight loss drugs with a warning about pulmonary aspiration ...
The FDA warns GLP-1 weight loss drug users of aspiration risks during anaesthesia Learn what this update means and how to ...
The FDA warned that VitalityXtra and PeakMax ... Two dietary supplements have been recalled after "hidden" drugs were found inside them that were not listed on the label. A man pours pills onto his ...
The FDA has proposed removing phenylephrine, a widely used ingredient to treat nasal congestion, from over-the-counter cold medications.Last year, an FDA advisory committee concluded that the oral ...
The U.S. Food and Drug Administration's recall concerns two butter products produced by Continental Dairy ...
Dallas Morning News on MSN1d
FDA adds new warning to weight loss drugs including WegovyOne of the drugs’ impacts is to slow down the process of emptying ... inhaling fluid or food into the lungs — while under ...
On November 5, the US Food and Drug Administration (FDA ... “This was a safety-related labeling change for the glucagon-like peptide 1 receptor agonist product class,” an FDA spokesperson told ...
The FDA has approved updated labeling for Flublok (influenza vaccine) to include new safety data involving pregnant individuals.
Both Ozempic and Mounjaro are approved by the FDA to treat Type 2 diabetes, but some doctors prescribe the medication ...
The Prescription Drug User Fee Act date refers to the deadline set by the FDA for reviewing a NDA or Biologics License Application.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback